| トルコ | オーストリア | スペイン | |
| 白血病化学療法 | から $5,000 | ≈ $15,000 | から $6,200 |
| 治療的アフェレーシス | から $4,500 | ≈ $1,800 | ≈ $1,400 |
| 乳癌化学療法 | から $1,900 | ≈ $9,500 | から $1,700 |
| CAR-T細胞療法 | から $200,000 | ≈ $280,000 | から $386,100 |
ヴォルフガング・ケストラー大学教授(医学博士)は、ウィーン私立病院(Wiener Privatklinik)にて20年以上の経験を持つ、オーストリアの著名な腫瘍内科医です。
ドラッハ教授は1,100件以上の腫瘍学的手術を執刀し、ウィーン大学病院にて多発性骨髄腫および悪性リンパ腫プログラムを主導しています。
Assoc. Prof. Priv.-Doz. Dr. Alexander W. Hauswirth is a specialist in internal medicine and haemato‑oncology at JUVENIS. Since 2010, he has served as the lead senior physician for Haematology/Haemostaseology and Oncology at the Clinic for Internal Medicine I, Medical University of Vienna/AKH Vienna, Austria’s largest hospital.
He earned his medical degree from the University of Vienna in 1999. He received the venia docendi in 2010 and was appointed Associate Professor in 2012. He completed an additional haemato‑oncology qualification in 2014. As a Schrödinger Fellow in Salamanca in 2009–2010, he researched CLL stem and precursor cells. He has published regularly since 2000.
Accreditations include Austrian Medical Chamber diplomas in emergency medicine (since 2009) and sports medicine (2018). Awards include the Schrödinger Fellowship (2009), the ÖGHO award (2009), and the European Society of Chemotherapy poster award (2003). Clinical focus: anaemias, leukaemias, lymph node disorders, clotting and anticoagulation, and pre‑operative clearance. Languages: German and English.